Medical Devices Startups
6,372 companies tagged Medical Devices, with their investors and founders.
ReGelTec develops injectable hydrogel technology for the repair of the nucleus pulposus of the intervertebral disc, targeting interventional pain management and spine care. The company is a medical device (MedTech) startup combining academic research in crosslinked polymers with experienced medical device executives.
2 investors
Relief Cardiovascular develops transcatheter smart implant systems for volume management in congestive heart failure, including the Relief System, a preload-modulating implant for inferior vena cava flow modulation with autonomous hemodynamic monitoring. It targets heart failure patients with diuretic-resistant congestion whose needs are inadequately met by pharmaceuticals and legacy devices.
2 investors
Remedee Labs develops medical devices that use endorphin stimulation via wearable bracelets to treat rheumatologic pain conditions and fibromyalgia, primarily marketed in France.
2 investors
REMEDI8 provides compliance inspection, repair, and reporting services for fire safety systems in healthcare facilities, including fire doors, dampers, and barriers.
2 investors
Remmie Health develops AI-powered ear-nose-throat diagnostic solutions for families and telemedicine providers, using a digital otoscope and app to reduce unnecessary doctor visits and improve diagnostic accuracy in primary care.
2 investors
Reperio Health builds diagnostic tools and automated systems powered by AI/ML for enterprise deployment, with infrastructure for real-time data processing. The company serves large enterprises across technology and other sectors.
2 investors
Resalis Therapeutics develops antisense oligonucleotide therapies targeting microRNA pathways for metabolic disorders. The company is advancing RES-010, a treatment candidate for obesity, fatty liver disease, and related metabolic disorders.
2 investors
Resistell develops a nanomotion-based diagnostic device for rapid phenotypic antibiotic susceptibility testing (AST), aimed at accelerating detection of antibiotic resistance in hospital settings. The Swiss company's IVD product is intended for clinical microbiology use with bacterial pathogens.
2 investors
Resolve Stroke develops software-driven ultrasound technology for medical imaging and diagnosis. The company serves healthcare providers and medical professionals in diagnostic and interventional radiology, with expertise in clinical development and device innovation.
2 investors
Resonant Link Inc. developed wireless power technology and is no longer operating as an active business, now managing and licensing its patent portfolio for non-medical wireless power. Its medical device wireless power work continues through a related entity, Resonant Link Medical.
2 investors
Resonant develops antibody-based therapeutics for oncology using deep cancer biology and drug discovery expertise. The company leverages world-class antibody engineering capabilities to advance oncology drug programs.
2 investors
Respiosa develops a minimally invasive surgical implant to treat obstructive sleep apnea by preventing tongue collapse during sleep, targeting patients for whom current treatments like CPAP are ineffective or poorly tolerated.
2 investors
Respira develops inhaled therapeutic products for pulmonary diseases, including a novel dry-powder inhalation device and lead product candidate RT234 for pulmonary arterial hypertension. The company focuses on creating drug-device combination products using advanced particle engineering and formulation technologies.
2 investors
Restorative Neurotechnologies develops digital therapies certified as medical devices (MindLenses Professional) for cognitive rehabilitation in neurological conditions and neurodevelopmental disorders such as post-stroke recovery and ADHD, used in public and private healthcare facilities. It also offers MindPAth, a consumer-oriented cognitive training product, with a market focus in Italy and Europe.
2 investors
RestorixHealth develops and operates wound care centers in partnership with hospitals, delivers professional wound care services in nursing facilities and home settings, and coordinates wound care supplies to improve patient access and outcomes.
2 investors
Rev Genomics uses genomic selection, tissue culture, and molecular analysis to develop high-value crop cultivars for breeders and seed banks. The company creates novel plant phenotypes and provides molecular fingerprinting and breeding technology primarily for specialty crops in California.
2 investors
RevBio develops a biomimetic bone adhesive platform derived from marine biology for bone repair and regenerative applications across dental, orthopedic, and neurosurgical indications. The company is conducting first-in-human clinical trials on its regenerative bone glue technology.
2 investors
Revisto offers an AI-driven platform that automates compliance review and approval of promotional and marketing materials for pharmaceutical companies, learning from regulations, industry best practices, and customer history. It aims to reduce review cycle time and support the creation of compliant, personalized content, and counts a Top 5 pharmaceutical company among its customers.
2 investors
RevMedica develops smart surgical stapling and soft tissue management systems for minimally invasive and robotic procedures, designed to provide real-time intraoperative data and improve clinical decision-making for surgeons. The platform aims to enhance patient safety and reduce operating room waste while maintaining environmental sustainability.
2 investors
Reyedar develops an AI-powered eye tracking system that detects biomarkers of neurological and visual health conditions such as glaucoma and Parkinson's disease through automated oculomotor testing. The company serves optometry centers, hospitals, clinics, and clinical research centers seeking rapid, non-invasive screening for neurovisual disorders.
2 investors
Rhaeos develops FlowSense, a noninvasive wireless wearable skin patch that monitors fluid flow in the body, initially targeting hydrocephalus patients who depend on implantable shunts for cerebrospinal fluid management.
2 investors
RheaVita manufactures scalable freeze-dryer systems for pharmaceutical and vaccine development, ranging from R&D models to GMP-compliant production units. The company serves pharmaceutical and biotech manufacturers seeking to accelerate drug development and lyophilization scaling.
2 investors
Ribolia (ηεηη©) is a pioneer in RNAi technology and small nucleic acid drug development, with research platforms covering drug delivery, chemical modification, and multi-target drug development. The company serves patients with chronic diseases including cardiovascular, metabolic, kidney, and liver conditions through its siRNA pipeline.
2 investors
RiboNova is a biopharmaceutical company developing small molecule drugs and precision medicines targeting transfer RNA for the treatment of mitochondrial disease. The company operates a proprietary drug discovery platform with a Phase-2 ready candidate in its pipeline.
2 investors